Harris Hyman IV insider trades: Medassets (MDAS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Harris reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 12, 2014 | MDAS | ↓ Sell | 3,334 | $20.50 | $68K | Direct | Nov 12, 2014 (0d) |
| Aug 29, 2013 | MDAS | ↓ Sell | 3,199 | $23.26 | $74K | Direct | Sep 3, 2013 (5d) |
| Aug 26, 2013 | MDAS | ↓ Sell | 5,985 | $23.50 | $141K | Direct | Aug 28, 2013 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Harris Hyman IV's insider trades
Harris Hyman IV is a director at Medassets (MDAS). Since Aug 26, 2013, Harris has reported no open-market purchases and 3 sales worth $283K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), option exercises (4 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDAS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.